Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacia Diagnostics plans fightback after German defeat

This article was originally published in Clinica

Executive Summary

Axis Biochemicals (Norway) has been cleared of charges of infringing a patent held by Swedish company Pharmacia Diagnostics (see Clinica No 629, p 16). A Munich court has ruled that Axis' CDT test for alcoholism does not infringe the patent under which Pharmacia, Axis' only rival, manufactures its CDTect test. A Pharmacia spokesperson told Clinica the company intends to appeal against the decision. Axis administrative director Steinar Lein estimates the potential world market for a test for alcoholism at $75 million per year, of which $6 million is in Germany, according to Reuters.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT090072

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel